Literature DB >> 1479558

Pharmacoimmunodynamics of methylprednisolone: trafficking of helper T lymphocytes.

L E Fisher1, E A Ludwig, W J Jusko.   

Abstract

A two-compartment closed model was used to characterize the cell trafficking behavior of helper T cells in response to various single doses of methylprednisolone. Steroids are assumed to inhibit the circadian-determined cell return from extravascular sites to blood in a classic inhibitory pattern reflected by an IC50. The rate of cell efflux from tissues is modeled with a cosine function having a period of 24 hr and a maximum at about 1 AM. Nonlinear least-squares regression employing differential equations was used to analyze helper T-cell data from three human studies from our laboratory. The IC50 value of methylprednisolone of 12-19 ng/ml approximates receptor KD values. Simulations were performed to demonstrate the log-linear role of steroid dose or AUC on the integral of effect of helper T cells over a wide range of methylprednisolone doses. This pharmacodynamic model allows flexibility for characterizing any type of steroid dosing regimen and is relevant in describing complex response data for corticosteroid immunosuppressive effects in man.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1479558      PMCID: PMC4207299          DOI: 10.1007/bf01062461

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  20 in total

1.  Circadian rhythms in circulating T lymphocyte subtypes and plasma testosterone, total and free cortisol in five healthy men.

Authors:  F A Lévi; C Canon; Y Touitou; J Sulon; M Mechkouri; E D Ponsart; J P Touboul; J M Vannetzel; I Mowzowicz; A Reinberg
Journal:  Clin Exp Immunol       Date:  1988-02       Impact factor: 4.330

2.  Diurnal variation of lymphocyte subsets identified by monoclonal antibodies.

Authors:  J V Bertouch; P J Roberts-Thomson; J Bradley
Journal:  Br Med J (Clin Res Ed)       Date:  1983-04-09

3.  The migration of lymphocytes across specialized vascular endothelium. IV. Prednisolone acts at several points on the recirculation pathways of lymphocytes.

Authors:  J H Cox; W L Ford
Journal:  Cell Immunol       Date:  1982-01-15       Impact factor: 4.868

4.  Corticosteroid effects on circulating lymphocyte subset levels in normal humans.

Authors:  B Zweiman; P C Atkins; P M Bedard; S L Flaschen; R P Lisak
Journal:  J Clin Immunol       Date:  1984-03       Impact factor: 8.317

5.  Studies on the bioperiodicity of the immune response. I. Circadian rhythms of human T, B, and K cell traffic in the peripheral blood.

Authors:  T Abo; T Kawate; K Itoh; K Kumagai
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

6.  Mechanisms of corticosteroid action on lymphocyte subpopulations. I. Redistribution of circulating T and b lymphocytes to the bone marrow.

Authors:  A S Fauci
Journal:  Immunology       Date:  1975-04       Impact factor: 7.397

7.  Pharmacokinetics and pharmacodynamics of methylprednisolone when administered at 8 am versus 4 pm.

Authors:  L E Fisher; E A Ludwig; J A Wald; R R Sloan; E Middleton; W J Jusko
Journal:  Clin Pharmacol Ther       Date:  1992-06       Impact factor: 6.875

8.  The effects of triacetyloleandomycin and oleandomycin phosphate on the glucocorticoid receptor in cultured skin fibroblasts.

Authors:  R J Engler; R Y Chestnut; G C Borst; C Eil
Journal:  J Allergy Clin Immunol       Date:  1985-03       Impact factor: 10.793

9.  Pharmacokinetics and pharmacodynamic modeling of direct suppression effects of methylprednisolone on serum cortisol and blood histamine in human subjects.

Authors:  A N Kong; E A Ludwig; R L Slaughter; P M DiStefano; J DeMasi; E Middleton; W J Jusko
Journal:  Clin Pharmacol Ther       Date:  1989-12       Impact factor: 6.875

10.  Prednisone-induced alterations of circulating human lymphocyte subsets.

Authors:  J D Slade; B Hepburn
Journal:  J Lab Clin Med       Date:  1983-03
View more
  20 in total

1.  Mechanism-based pharmacodynamic models of fluoroquinolone resistance in Staphylococcus aureus.

Authors:  Philip Chung; Patrick J McNamara; Jeffrey J Campion; Martin E Evans
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

2.  Pharmacokinetic and pharmacodynamic interactions between dehydroepiandrosterone and prednisolone in the rat.

Authors:  G M Meno-Tetang; Y Y Hon; S Van Wart; W J Jusko
Journal:  Drug Metabol Drug Interact       Date:  1999

3.  Evaluation of dose-related pharmacokinetics and pharmacodynamics of prednisolone in man.

Authors:  J A Wald; R M Law; E A Ludwig; R R Sloan; E Middleton; W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1992-12

4.  Receptor/gene/protein-mediated signaling connects methylprednisolone exposure to metabolic and immune-related pharmacodynamic actions in liver.

Authors:  Vivaswath S Ayyar; Siddharth Sukumaran; Debra C DuBois; Richard R Almon; Jun Qu; William J Jusko
Journal:  J Pharmacokinet Pharmacodyn       Date:  2018-04-27       Impact factor: 2.745

Review 5.  Expanding clinical applications of population pharmacodynamic modelling.

Authors:  C Minto; T Schnider
Journal:  Br J Clin Pharmacol       Date:  1998-10       Impact factor: 4.335

Review 6.  Characteristics of indirect pharmacodynamic models and applications to clinical drug responses.

Authors:  A Sharma; W J Jusko
Journal:  Br J Clin Pharmacol       Date:  1998-03       Impact factor: 4.335

7.  Modeling interactions between adrenal suppression and T-helper lymphocyte trafficking during multiple dosing of methylprednisolone.

Authors:  F S Chow; A Sharma; W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1999-12

Review 8.  Pharmacokinetic/pharmacodynamic modeling in inflammation.

Authors:  Hoi-Kei Lon; Dongyang Liu; William J Jusko
Journal:  Crit Rev Biomed Eng       Date:  2012

9.  Population pharmacokinetics and pharmacodynamics of ponesimod, a selective S1P1 receptor modulator.

Authors:  Andreas Krause; Patrick Brossard; Daniele D'Ambrosio; Jasper Dingemanse
Journal:  J Pharmacokinet Pharmacodyn       Date:  2014-06-15       Impact factor: 2.745

10.  Gender-based effects on methylprednisolone pharmacokinetics and pharmacodynamics.

Authors:  K H Lew; E A Ludwig; M A Milad; K Donovan; E Middleton; J J Ferry; W J Jusko
Journal:  Clin Pharmacol Ther       Date:  1993-10       Impact factor: 6.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.